2024 Leads Pharma Prescription 
Clarivate
APRIL 18, 2024
RxPass offers more than 50 select prescriptions at no additional cost for $5 per month. In classic Amazon style, its pharmacy offers two-day shipping on prescriptions by mail, with same-day delivery available in seven markets, with plans to add a dozen more cities by year end.
Eversana Intouch
MARCH 19, 2024
That’s why in 2024, we find ourselves still failing women in healthcare. They are more likely than men to suffer chronic conditions and use prescription drugs across all age groups. When it comes to healthcare, however, this model often fails to consider the good of all. Women represent more of the health care system than men.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
NOVEMBER 14, 2023
This collaboration builds on Sanofi’s recent announcement to lower the list price for Lantus and cap OOP costs at $35 for all patients with commercial insurance, which goes into effect January 1, 2024. The price is available to cash-paying patients with a valid prescription. Currently, an estimated 37.3 of the U.S.
pharmaphorum
JANUARY 24, 2023
Pharma will be focusing more on relevant research, support, and a better mix of non-promotional and promotional interaction. Given the funding environment for innovative medicines that is faced by all pharma, large or small, once assets are approved, however, this 2023 reset seems a necessary response.
pharmaphorum
OCTOBER 3, 2022
The third ALS treatment to be given FDA approval, following Mitsubishi Tanabe’s Radicava ($170,000 per year) and generic drug riluzole – Relyvrio is priced at around $12,500 per 28-day prescription. Clearer’ data isn’t expected until 2024, with results from a late-stage phase 3 PHOENIX trial of around 600 patients due at that time.
PM360
APRIL 7, 2023
This is especially significant for manufacturers of high-cost specialty drugs, who will now face a recurring additional 20% charge on virtually every prescription fill. pharma sales in 2020) and the size of 340B discounts (25-50%), companies may see significantly reduced revenues for important products. The 340B battle will rage on.
Clarivate
DECEMBER 19, 2022
The plans are profitable and continue to draw new Medicare enrollees, leading all top payers to make investments in retaining and attracting enrollees. Expansion opportunities for 2024 are relatively obvious, since the partners could expand to the three states with Walmart Health locations (Arkansas, Illinois, Texas ).
Expert insights. Personalized for you.
52 
Let's personalize your content